UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 4, 2013
Apricus Biosciences, Inc.
(Exact name of registrant as specified in its charter)
Registrants telephone number, including area code: (858) 222-8041
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On January 4, 2013, Henry Esber, Ph.D. tendered his resignation as a member of the board of directors (the Board) of Apricus Biosciences, Inc. (the Company), effective immediately. Dr. Esber did not serve on any committees of the Board at the time of his resignation. Dr. Esber resigned for personal reasons and his resignation was not related to a disagreement with the Company.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.